View Older Stories View More Recent Stories

Sep 6, 2022 08:00AM Daré Bioscience to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Aug 29, 2022 08:04AM Dare Bioscience (DARE) Reports Interim Analysis of Phase 2b RESPOND Study of Sildenafil Cream
Aug 29, 2022 08:00AM Daré Bioscience Announces Interim Analysis of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder
Aug 24, 2022 08:00AM Daré Bioscience, Inc. Announces Global Licensing Rights to the Novel Antimicrobial Glycerol Monolaurate for Vaginal Health
Aug 9, 2022 08:00AM Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company Update
Aug 2, 2022 08:00AM Daré Bioscience to Host Second Quarter 2022 Financial Results and Company Update Conference Call and Webcast on August 9, 2022
Jul 7, 2022 08:00AM Daré Bioscience to Participate in Maxim Group Women’s Health Panel
Jun 30, 2022 08:04AM Dare Bioscience (DARE) Announces Closing of Global License Agreement with Organon to Commercialize XACIATO, FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis
Jun 30, 2022 08:00AM Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Ba
Jun 24, 2022 08:00AM Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022
Jun 6, 2022 08:00AM Daré Bioscience to Participate in the 2022 BIO International Convention
May 16, 2022 08:00AM Daré Bioscience to Participate in H.C. Wainwright Global Investment Conference
May 12, 2022 06:00AM Daré Bioscience Reports First Quarter 2022 Financial Results and Provides a Company Update
May 11, 2022 08:00AM Daré Bioscience Announces NIH Grant Award
May 5, 2022 08:00AM Daré Bioscience to Host First Quarter 2022 Financial Results and Company Update Conference Call and Webcast on May 12, 2022
Apr 14, 2022 08:00AM Daré Bioscience to Participate in Upcoming Conference
Apr 12, 2022 08:04AM Dare Bioscience (DARE) Initiates Phase 1/2 Clinical Study of DARE-HRT1
Apr 12, 2022 08:00AM Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-HRT1
Mar 31, 2022 08:00AM Daré Bioscience Reports Full-Year 2021 Financial Results and Provides a Company Update
Mar 31, 2022 07:02AM Organon (OGN) and Dare (DARE) Enter Agreement to Commercialize XACIATO
Mar 31, 2022 07:00AM Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Va
Mar 24, 2022 08:00AM Daré Bioscience to Host Full-year 2021 Financial Results and Company Update Conference Call and Webcast on March 31, 2022
Mar 22, 2022 08:00AM Daré Bioscience to Present at the Maxim 2022 Virtual Growth Conference
Mar 2, 2022 08:00AM Daré Bioscience to Participate in Upcoming Conferences
Feb 7, 2022 08:00AM Daré Bioscience to Participate in Upcoming Conferences
Jan 4, 2022 08:00AM Daré Bioscience to Participate in H.C. Wainwright BIOCONNECT 2022 Conference
Dec 7, 2021 04:16PM Dare Bioscience (DARE) Confirms FDA Approval of XACIATO (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial Vaginosis
Dec 7, 2021 04:15PM Daré Announces FDA Approval of XACIATO™ (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial Vaginosis
Nov 10, 2021 08:00AM Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company Update
Nov 9, 2021 08:00AM Daré Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference
Nov 3, 2021 08:00AM Daré Bioscience to Host Third Quarter 2021 Financial Results and Company Update Conference Call and Webcast on November 10, 2021
Oct 6, 2021 08:51AM Daré Bioscience to Participate in Panel Discussion at DTC Perspectives’ Xpectives.Health Summit, October 12-14, 2021
Sep 27, 2021 08:13AM Dare Bioscience (DARE) Awarded NIH Grant for Development of DARE-LARC1
Sep 27, 2021 08:00AM Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1
Sep 23, 2021 08:00AM Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy
Sep 22, 2021 08:00AM Daré Bioscience to Present at the 2021 Cantor Virtual Global Healthcare Conference
Sep 8, 2021 08:00AM Daré Bioscience to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Sep 7, 2021 08:00AM Daré Bioscience to Participate in Panel Discussion at Women’s Health Innovation Summit
Sep 1, 2021 08:00AM Daré Bioscience to Present at the 13th European Congress on Menopause and Andropause
Aug 12, 2021 08:00AM Daré Bioscience Reports Second Quarter 2021 Financial Results and Provides a Company Update
Aug 9, 2021 08:01AM Dare Bioscience (DARE) Announces FDA Acceptance and Priority Review of New Drug Application for DARE-BV1 for the Treatment of Bacterial Vaginosis
Aug 9, 2021 08:00AM Daré Bioscience Announces FDA Acceptance and Priority Review of New Drug Application for DARE-BV1 for the Treatment of Bacterial Vaginosis
Aug 5, 2021 08:00AM Daré Bioscience to Host Second Quarter 2021 Financial Results and Company Update Conference Call and Webcast on August 12, 2021
Jul 26, 2021 08:00AM Daré Bioscience to Present at the 2021 Controlled Release Society Virtual Annual Meeting to be held July 25-29, 2021
Jul 12, 2021 06:24AM Dare Bioscience (DARE) Announces Collaborative Research Agreement for the Pivotal Phase 3 Study of Ovaprene, an Investigational Hormone-Free Monthly Contraceptive
Jul 12, 2021 05:45AM Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive
Jun 28, 2021 08:02AM Dare Bioscience (DARE) Announces Positive Phase 1 Results for DARE-HRT1
Jun 28, 2021 08:00AM Daré Bioscience Announces Positive Phase 1 Results for DARE-HRT1
Jun 4, 2021 08:00AM Daré Bioscience to Present at 2021 BIO Digital
May 13, 2021 08:00AM Daré Bioscience Reports First Quarter 2021 Financial Results and Provides a Company Update
View More Recent Stories View Older Stories